Effect of Self-Efficacy Support on Medication Adherence and Self-Efficacy Levels in Hypertension Patients: A Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ataturk University
- Enrollment
- 63
- Locations
- 2
- Primary Endpoint
- Self-Efficacy - Efficacy Scale
Study Overview
Brief Summary
Background:Health professionals are responsible for the education of hypertension patients.
Aim:The aim of this research is to see how self-efficacy support affects hypertension patients' medication adherence and self-efficacy levels.
Methods: This research is randomized controlled interventional research. The research is conducted inTurkey June-December2021.The research sample included 63hypertension patients who met the research's research requirements.According to the sequence of the arrival at the hospital, data were separated into groups with odd(intervention group)and double(control group)numbers.The necessary forms for both groups' pre-test data were filled out face-to-face. The intervention group received hands-on blood pressure measurement training with the "Hypertension Training Manual",including how to self-measure blood pressure.Over the course of the research, patients were asked to check their blood pressure twice a day at home and record the results.The patients in the intervention group were reminded of their blood pressure measurement three times a week by SMStechnique for three months to avoid forgetting it.Three months later, the same forms for the post-test data of both groups were filled out with an online survey method.The data were evaluated using the single-blind study.
Detailed Description
Background:Health professionals are responsible for the education of hypertension patients.
Aim:The aim of this research is to see how self-efficacy support affects hypertension patients' medication adherence and self-efficacy levels.
The Research's Population and Sample Hypertension patients who applied to the cardiology outpatient clinics at a Hospital in Turkey between June and December 2021 formed the target population of the research. The research sample included 63 hypertension patients over the age of 18 who met the research requirements and agreed to participate.
A priori power analysis was used to determine the sample size, and it was determined that each of the intervention and control groups needed at least 30 hypertension patients for the research's power to exceed 80% at the 95% confidence interval, 0.05 significance level, and medium effect size. Given the possibility of data loss owing to a variety of factors, it was decided to include 100 hypertension patients in the research sample. Because 12 patients wished to withdraw from the research and 25 patients did not complete the final applications, the research sample consisted of 63 hypertension patients, 31 in the intervention group and 32 in the control group.
Criteria for Research Inclusion All intervention and control groups were required to meet the inclusion criteria below.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Investigator)
Eligibility Criteria
- Ages
- 50 Years to 72 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •All intervention and control groups were required to meet the inclusion criteria below.
- •With a diagnosis of essential hypertension, follow up for at least 6 months,
- •Using antihypertensive drugs,
- •Not changing the antihypertensive medication in the last 1 month,
- •Not having mental or communication problems,
- •Being the age of 18 or older,
- •Having at least primary education level,
- •Not being a pregnant or nursing mother.
Exclusion Criteria
- •All intervention and control groups were required to meet the inclusion criteria below.
- •With a diagnosis of essential hypertension, follow up for at least 6 months,
- •Using antihypertensive drugs,
- •Not changing the antihypertensive medication in the last 1 month,
- •Not having mental or communication problems,
- •Being the age of 18 or older,
- •Having at least primary education level,
- •Not being a pregnant or nursing mother.
Outcomes
Primary Outcomes
Self-Efficacy - Efficacy Scale
Time Frame: 3months
The scale evaluates generic self-efficacy-efficacy perception and does not belong to any subjective category. The Self-Efficacy-Efficacy Scale is a 23-item, 5-point Likert-type scale with a minimum of 23 points and a maximum of 115 points.
Medication Adherence Self-Efficacy Scale in Hypertensive Patients
Time Frame: 3months
The scale consists of 13 items and is in a four-point Likert type. The scale can be used to determine the lowest 13 and highest 52 points. The increase in the scale score shows that the individuals' compliance with the antihypertensive medication is above average.
Secondary Outcomes
No secondary outcomes reported
Investigators
Bahar Ciftci
Principal Investigator
Ataturk University